From DCAT Value Chain Insights (VCI)
Pfizer has appointed Dr. Ole Isacson to the position of chief scientific officer of the neuroscience research unit and senior vice president, effective on September 16. Dr. Isacson is a professor of neurology at Harvard Medical School, and will continue to serve in an educational role. He is also a founding director of the Neuroregeneration Institute at McLean Hospital. Dr. Isacson will report directly to Mikael Dolsten, president of worldwide research and development.
Thank you for reading DCAT Value Chain Insights (VCI), an information resource from the
Drug, Chemical & Associated Technologies Association (DCAT).
Learn more and sign up to receive a complimentary subscription